RT @AnnSurgOncol: AHEAD OF PRINT: 1 Versus 2-cm Excision Margins for pT2-pT4 Primary #CutaneousMelanoma (MelMarT): A Feasibility Study. htt…
RT @AnnSurgOncol: AHEAD OF PRINT: 1 Versus 2-cm Excision Margins for pT2-pT4 Primary #CutaneousMelanoma (MelMarT): A Feasibility Study. htt…
RT @AnnSurgOncol: AHEAD OF PRINT: 1 Versus 2-cm Excision Margins for pT2-pT4 Primary #CutaneousMelanoma (MelMarT): A Feasibility Study. htt…
RT @AnnSurgOncol: AHEAD OF PRINT: 1 Versus 2-cm Excision Margins for pT2-pT4 Primary #CutaneousMelanoma (MelMarT): A Feasibility Study. htt…
RT @AnnSurgOncol: AHEAD OF PRINT: 1 Versus 2-cm Excision Margins for pT2-pT4 Primary #CutaneousMelanoma (MelMarT): A Feasibility Study. htt…
RT @AnnSurgOncol: AHEAD OF PRINT: 1 Versus 2-cm Excision Margins for pT2-pT4 Primary #CutaneousMelanoma (MelMarT): A Feasibility Study. htt…
RT @AnnSurgOncol: AHEAD OF PRINT: 1 Versus 2-cm Excision Margins for pT2-pT4 Primary #CutaneousMelanoma (MelMarT): A Feasibility Study. htt…
RT @AnnSurgOncol: AHEAD OF PRINT: 1 Versus 2-cm Excision Margins for pT2-pT4 Primary #CutaneousMelanoma (MelMarT): A Feasibility Study. htt…
RT @AnnSurgOncol: AHEAD OF PRINT: 1 Versus 2-cm Excision Margins for pT2-pT4 Primary #CutaneousMelanoma (MelMarT): A Feasibility Study. htt…
AHEAD OF PRINT: 1 Versus 2-cm Excision Margins for pT2-pT4 Primary #CutaneousMelanoma (MelMarT): A Feasibility Study. https://t.co/KF9uu1IEUo @davidgyorki @McMastersKelly @SocSurgOnc https://t.co/Yd5zutxocY
RT @davidgyorki: Great to see the pilot data from the MelMarT # melanoma margins trial in press @AnnSurgOncol - Huge effort from all @ANZMT…
RT @davidgyorki: Great to see the pilot data from the MelMarT # melanoma margins trial in press @AnnSurgOncol - Huge effort from all @ANZMT…
RT @davidgyorki: Great to see the pilot data from the MelMarT # melanoma margins trial in press @AnnSurgOncol - Huge effort from all @ANZMT…
RT @davidgyorki: Great to see the pilot data from the MelMarT # melanoma margins trial in press @AnnSurgOncol - Huge effort from all @ANZMT…
RT @davidgyorki: Great to see the pilot data from the MelMarT # melanoma margins trial in press @AnnSurgOncol - Huge effort from all @ANZMT…
RT @davidgyorki: Great to see the pilot data from the MelMarT # melanoma margins trial in press @AnnSurgOncol - Huge effort from all @ANZMT…
Great to see the pilot data from the MelMarT # melanoma margins trial in press @AnnSurgOncol - Huge effort from all @ANZMTG and all international collaborators! Fingers crossed for full funding coming through later this year! https://t.co/DNwAmXuPu0
MelMarT, a great trial and a great paper! The question about margins in melanoma just needs to be solved! @marc_moncrieff https://t.co/SNJJu2GZ3C